mOPV1

BIOLOGICAL2 trials

Sponsors

Aga Khan University, Centers for Disease Control and Prevention

Conditions

PolioPoliomyelitis

Phase 4

Monovalent Oral Poliovirus Vaccine Type 1 Intestinal and Humoral Immunity Study

CompletedNCT03722004

Centers for Disease Control and PreventionPoliomyelitis

Start: 2018-12-18End: 2019-12-19Updated: 2021-02-21

Unknown Phase

Pakistan Short Interval mOPV1 Compared With Standard Interval mOPV1 and bOPV 1,3

CompletedNCT01586572

Aga Khan UniversityPolio

Start: 2012-04-30End: 2013-05-31Updated: 2015-06-29

Related Papers

Poliovirus type 1 systemic humoral and intestinal mucosal immunity induced by monovalent oral poliovirus vaccine, fractional inactivated poliovirus vaccine, and bivalent oral poliovirus vaccine: A randomized controlled trial.

2023-08-294 citations

Monovalent type-1 oral poliovirus vaccine given at short intervals in Pakistan: a randomised controlled, four-arm, open-label, non-inferiority trial.

2015-06-1716 citations